Benchmarking reverse docking through AlphaFold2 human proteome
Protein Science · 2024
DOI: 10.1002/pro.5167 ↗At a glance
Journal article in Protein Science, 2024. Written by Qing Luo and 5 co-authors. Institution: Centre in Artificial Intelligence Driven Drug Discovery, Faculty of Applied Sciences, Macao Polytechnic University, Macao, China. Major MEDLINE topics: Proteome, Molecular Docking Simulation. Cited 10 times so far (Crossref); 56 references. The full text is freely available in PubMed Central. Funded by: Macao Polytechnic University, Ministry of Education Singapore, National Key R&D Program of China.
Abstract (original language)
Predicting the binding of ligands to the human proteome via reverse‐docking methods enables the understanding of ligand's interactions with potential protein targets in the human body, thereby facilitating drug repositioning and the evaluation of potential off‐target effects or toxic side effects of drugs. In this study, we constructed 11 reverse docking pipelines by integrating site prediction tools (PointSite and SiteMap), docking programs (Glide and AutoDock Vina), and scoring functions (Glide, Autodock Vina, RTMScore, DeepRMSD, and OnionNet‐SFCT), and then thoroughly benchmarked their predictive capabilities. The results show that the Glide_SFCT (PS) pipeline exhibited the best target prediction performance based on the atomic structure models in AlphaFold2 human proteome. It achieved a success rate of 27.8% when considering the top 100 ranked prediction. This pipeline effectively narrows the range of potential targets within the human proteome, laying a foundation for drug target prediction, off‐target assessment, and toxicity prediction, ultimately boosting drug development. By facilitating these critical aspects of drug discovery and development, our work has the potential to ultimately accelerate the identification of new therapeutic agents and improve drug safety.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Centre in Artificial Intelligence Driven Drug Discovery, Faculty of Applied Sciences, Macao Polytechnic University, Macao, China.
- Shanghai Zelixir Biotech Company Ltd., China.
- School of Biological Sciences, Nanyang Technological University, Singapore.
- Shenzhen Zelixir Biotech Company Ltd., China.
- Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences, Shenzhen, China.
ORCID profiles: Jingjing Guo
Funding
- Macao Polytechnic University
- Ministry of Education Singapore
- National Key R&D Program of China
- National Key Research and Development Program of China
Cite
APA
Luo, Q., Wang, S., Li, H. Y., Zheng, L., Mu, Y., & Guo, J. (2024). Benchmarking reverse docking through AlphaFold2 human proteome. Protein Science. https://doi.org/10.1002/pro.5167
Vancouver
Luo Q, Wang S, Li HY, Zheng L, Mu Y, Guo J. Benchmarking reverse docking through AlphaFold2 human proteome. Protein Science. 2024. doi:10.1002/pro.5167
BibTeX
@article{Luo2024,
author = {Luo, Qing and Wang, Sheng and Li, Hoi Yeung and Zheng, Liangzhen and Mu, Yuguang and Guo, Jingjing},
title = {Benchmarking reverse docking through AlphaFold2 human proteome},
journal = {Protein Science},
year = {2024},
doi = {10.1002/pro.5167}
}
EUVIMED